|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Net premiums earned | |||||
| Net investment income | |||||
| Equity in earnings (loss) of unconsolidated subsidiaries | |||||
| Net investment gains (losses): | |||||
| Impairment losses | |||||
| Portion of impairment losses recognized in other comprehensive income (loss) before taxes | |||||
| Net impairment losses recognized in earnings | |||||
| Other net investment gains (losses) | |||||
| Total net investment gains (losses) | |||||
| Other income (expense) | |||||
| Total revenues | |||||
| Expenses | |||||
| Net losses and loss adjustment expenses | |||||
| Underwriting, policy acquisition and operating expenses: | |||||
| Operating expense | |||||
| DPAC amortization | |||||
| SPC U.S. federal income tax expense (benefit) | |||||
| SPC dividend expense (income) | |||||
| Interest expense | |||||
| Goodwill impairment | |||||
| Total expenses | |||||
| Gain on bargain purchase | |||||
| Income (loss) before income taxes | |||||
| Provision for income taxes: | |||||
| Current expense (benefit) | |||||
| Deferred expense (benefit) | |||||
| Total income tax expense (benefit) | |||||
| Net income (loss) | |||||
| Other comprehensive income (loss), after tax, net of reclassification adjustments | |||||
| Comprehensive income (loss) | |||||
| Earnings (loss) per share: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted average number of common shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
| Cash dividends declared per common share (in dollars per share) |
Loading...